Skip to main content

HBOT Evidence Digest · Pacific Hyperbarics

Diabetic Foot Ulcers

FDA status

Recognized

Evidence

Grade A · Strong

Coverage

Medicare ✓

ICD-10

E11.621, L97.509

Summary

Wagner grade III+ diabetic lower-extremity wounds that fail 30 days of standard care qualify for covered HBOT.

Typical protocol

2.0–2.4 ATA × 90 min, Daily, 5×/week, 30–40 sessions · UHMS / Medicare NCD 20.29

The evidence (4)

  1. [1] Hyperbaric oxygen therapy for chronic wounds (Cochrane systematic review)

    MIXED

    Kranke P, Bennett MH, Martyn-St James M, et al. · Cochrane Database of Systematic Reviews · 2015 · PMID 26106870

    Pooling 12 trials, the review found HBOT improved the chance of diabetic foot ulcers healing in the short term (around 6 weeks), though longer-term and amputation benefits were less certain and trial quality varied.

    Quality: Gold-standard systematic review; flags heterogeneity and modest trial quality.

  2. [2] Hyperbaric oxygen: its mechanisms and efficacy

    POSITIVE

    Thom SR · Plastic and Reconstructive Surgery · 2011 · PMID 21200283

    Widely cited review of HBOT mechanisms: raised dissolved oxygen, stem/progenitor cell mobilization, angiogenesis, and effects on inflammation and reperfusion injury.

    Quality: Standard mechanistic reference for the field.

  3. [3] Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes (HODFU study)

    POSITIVE

    Löndahl M, Katzman P, Nilsson A, Hammarlund C · Diabetes Care · 2010 · n=94 · PMID 20427685

    In this randomized, double-blind, placebo-controlled trial, adding HBOT to standard wound care significantly improved complete healing of chronic diabetic foot ulcers at one year versus placebo (hyperbaric air).

    Quality: Double-blind RCT with sham control — one of the strongest single trials in the field.

  4. [4] Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer

    POSITIVE

    Faglia E, Favales F, Aldeghi A, et al. · Diabetes Care · 1996 · n=70 · PMID 8941460

    Randomized trial in which adjunctive HBOT was associated with a significantly lower rate of major amputation in patients with severe ischemic diabetic foot ulcers.

    Quality: Early randomized evidence for limb salvage; unblinded.

Prepared by Pacific Hyperbarics · pacifichyperbarics.com · (619) 423-8200. Evidence grade reflects our editorial reading of the cited literature, last reviewed July 2026. Educational summary for clinicians — not a treatment directive. Verify coverage criteria against current payer policy.